US1982148A - Medicament for external use and method of producing the same - Google Patents
Medicament for external use and method of producing the same Download PDFInfo
- Publication number
- US1982148A US1982148A US629993A US62999332A US1982148A US 1982148 A US1982148 A US 1982148A US 629993 A US629993 A US 629993A US 62999332 A US62999332 A US 62999332A US 1982148 A US1982148 A US 1982148A
- Authority
- US
- United States
- Prior art keywords
- camphor
- menthol
- naphthalene
- trioxymethylene
- benzoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title description 7
- 238000000034 method Methods 0.000 title description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 42
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 38
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 29
- 241000723346 Cinnamomum camphora Species 0.000 description 28
- 229960000846 camphor Drugs 0.000 description 28
- 229930008380 camphor Natural products 0.000 description 28
- 239000000203 mixture Substances 0.000 description 21
- 239000005711 Benzoic acid Substances 0.000 description 19
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 19
- 235000010233 benzoic acid Nutrition 0.000 description 19
- 229940041616 menthol Drugs 0.000 description 19
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 18
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical group C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 description 18
- 239000003981 vehicle Substances 0.000 description 17
- 239000004615 ingredient Substances 0.000 description 16
- 239000007795 chemical reaction product Substances 0.000 description 13
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000002674 ointment Substances 0.000 description 8
- 230000003902 lesion Effects 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 235000019256 formaldehyde Nutrition 0.000 description 6
- 229960004279 formaldehyde Drugs 0.000 description 6
- 239000002904 solvent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000011787 zinc oxide Substances 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000002421 anti-septic effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 229940099259 vaseline Drugs 0.000 description 4
- 206010016717 Fistula Diseases 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229960001777 castor oil Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000003890 fistula Effects 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 230000007721 medicinal effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000000246 remedial effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229960004365 benzoic acid Drugs 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940075566 naphthalene Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Definitions
- the invention relates to a composition of matter in the form of a salve adapted to be applied externally to the body in the treatment of ulcers, lesions, burns, fistulas and the like.
- the salve may be employed for either medical or veterinary purposes.
- the principal initial ingredients preferably em; ployed in the preparation of the salve are trioxymethylene or formol, camphor, naphthalene, benzoic acid and menthol.
- zinc oxide is ordinarily employed as a filler, while solid or liquid Vaseline, castor oil, lanolin, or other like fatty substances may be likewise employed, according to the particular therapeutical use for which the salve is to be employed.
- the zinc oxide and the fatty substances may be considered as of minor importance as compared with the other ingredients which enter into the composition.
- the salve In preparing the composition several important factors must be taken into consideration, bearing in mind that the salve is to be employed for the treatment of burns, ulcers, lesions and the like.
- the salve must possess germicidal characteristics; secondly, it must be capable of neutralizing the toxins liberated by the bacteria, thirdly, the ingredients of the salve should be such as to avoid irritation of the tissue so far burns, ulcers, fistulas and the like, which is stable in character, does not destroy or harm the tissues, and is an energetic bactericide.
- No single ingredient is known to me which possesses these characteristics, and I have accordingly combined known ingredients to produce a new composition of matter having the desired characteristics which differ from those of the component constituents. Certain of these constituents, as for example trioxymethylene and naphthalene, possess dangerous characteristics when used alone and others do not possess the necessary healing qualities.
- trioxymethelene The bactericidal qualities of trioxymethelene are well recognized. However, as stated above, its use alone is frequently irritating and even dangerous. Accordingly I provide a vehicle for the trioxymethylene in which the latter is suspended in the colloidal state.
- the composition which I employ as a vehicle possesses remedial characteristics in addition to its function as a. carrier for the trioxymethylene or formol.
- cairphor naphthalene
- benzoic acid naphthalene
- menthol a chemical compound having different remedial characteristics than the initial materials
- benzoic acid and menthol likewise react to form the chemical compound, benzoate of menthyl.
- the reaction product of the camphor and naphthalene possesses bactericidal characteristics, and in addition serves as a vehicle for. the trioxymethylene, while the benzoate of menthyl is a reversible compound which is found to avoid the putrescent phenomena through the intermittent action of the body due to its reversibility.
- camphor Next, eight parts by weight of natural camphor are added and, although the melting point of camphor is 180 C., it is better to drop down the temperature to, 150 (3., because the benzoic acid acts as a melter. As soon as the camphor is melted, purified naphthalene is added in a proportion of about five parts by weight.
- Reactions take place between the benzoic acid and menthol and between the camphor and naphthalene.
- An excess of camphor is preferably employed-over the molecular quantity and such excess camphor acts as a solvent for the two reaction products.
- a quan: tity of trioxymethylene, or formol is added, pref erably. in a proportion of five parts by weight of trioxymethylene oriormol to one hundred parts by weight of the vehicle.
- the trioxymethylene is suspended in thecolloidal state in the vehicle. It seems probable that a reaction takes place between some of the trioxymethylene and the excess camphor.
- zinc oxide may be added, in a proportion of about 210 parts by weight to 100 parts of the vehicle and 5 parts of trioxymethylene.
- the zinc oxide serves as a filler principally, but is a desirable constituent by reason of its known medical properties.
- Vaseline, castor oil, lanolin or other fatty substances may be employed in addition to the above men--' tioned ingredients in order to give the salve the proper cnisistency.
- reaction product of the camphor and naphthalene may be used alone as a vehicle for the trioxymethylene or formol, but the medicinal properties of such a composition are not so effective as where-a. vehicle comprising both the reaction products of menthol and benzoic acid and of camphor and naphthalene are employed in conjunction with the trioxymethylene in colloidal suspension.
- Utilization of the bactericidal and antiseptic qualities of the trioxymethylene or formol constitutes an important factor in the improved composition, because when combined with the vehicle a stable composition is formed, with a considerable increase in the antiseptic properties. Moreover, the diifusing and impregnating qualities of the composition are much superior to those of the initial ingredients. Zinc oxide readily comp bines with the composition of matter, and while improving the physical characteristics of the composition as a whole, it also improves the remedial qualities of the composition.
- the medicament is intended for external use, and since it is a synergetic antiseptic, not toxic, and not destructive of tissues, it may be employed in the treatment of all, kinds of lesions caused or complicated by the presence of germs, particularly pyogenic micro-organisms.
- the medicament acts as a stimulant of cellular repairing in all cases of loss of substance, of pathological as well as of surgical origin, this effect being particularly noticeable in the case of lesions which are slow to heal.
- the medicament may be used in the customary manner known to the surgical practice; it is directly applied in the case of burns, ulcers, fistulas and the like.
- gauzes, tubes or dressings are impregnated with the medicament and applied according to the requirements of the case.
- the medicament is dissolved in liquid vaseline and conducted to the lesion through cathapplication which includes as an important ingredient thereof a reaction product of naphthalene and camphor.
- a medical composition adapted for external application which includes as an important ingredient thereof a reaction product of menthol and benzoic acid.
- a medical composition adapted for external application which includes as important ingredients the reaction products of (1) menthol and benzoic acid and (2) naphthalene and camphor.
- a stable medical composition adapted for external application which includes as an important ingredient trioxymethylene colloidally suspended in a vehicle, which vehicle includes as an important ingredient a reaction product of naphthalene and camphor.
- a stable medical composition adapted for external application which includes as an important ingredient trioxymethylene colloidally suspended in a vehicle comprising (1) a reaction. product of benzoic acid and menthol and (2) a reaction product of camphor and naphthalene.
- a process of producing a stable medical composition which comprises mixing melted benzoic acid and menthol, then adding camphor and naphthalene, heating until a reaction takes place between the benzoic acid and menthol and between the camphor and naphthalene, and then adding trioxymethylene or formol and mixing to obtain a colloidal suspension of the trioxymethylene in a vehicle comprising the reaction products of the menthol and benzoic acid and of the camphor and naphthalenea 7.
- a medical composition as set forth in claim 7 1, together with a solvent for the reaction prod-' uct consisting of uncombined camphor.
- a process of producing a'vehicle for trioxymethylene, having medicinal properties which comprises mixing melted benzoic acid and menthol in substantially molecular proportions, then adding camphor and naphthalene, the camphor being employed in excess of the molecular proportions, and heating until a reaction takes place between the benzoic acid and menthol and between the camphor and naphthalene, the excess camphor serving as a solvent for the reac tion products.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Description
Patented Nov. 27, 1934 UNITED STATES PATENT FFig-E MEDICAMENT FOR EXTERNAL USE AND No Drawing. Application August 22, 1932, Serial No. 629,993
10 Claims.
The invention relates to a composition of matter in the form of a salve adapted to be applied externally to the body in the treatment of ulcers, lesions, burns, fistulas and the like. The salve may be employed for either medical or veterinary purposes.
The principal initial ingredients preferably em; ployed in the preparation of the salve are trioxymethylene or formol, camphor, naphthalene, benzoic acid and menthol. In addition to these ingredients zinc oxide is ordinarily employed as a filler, while solid or liquid Vaseline, castor oil, lanolin, or other like fatty substances may be likewise employed, according to the particular therapeutical use for which the salve is to be employed. The zinc oxide and the fatty substances may be considered as of minor importance as compared with the other ingredients which enter into the composition.
In preparing the composition several important factors must be taken into consideration, bearing in mind that the salve is to be employed for the treatment of burns, ulcers, lesions and the like. First, the salve must possess germicidal characteristics; secondly, it must be capable of neutralizing the toxins liberated by the bacteria, thirdly, the ingredients of the salve should be such as to avoid irritation of the tissue so far burns, ulcers, fistulas and the like, which is stable in character, does not destroy or harm the tissues, and is an energetic bactericide. No single ingredient is known to me which possesses these characteristics, and I have accordingly combined known ingredients to produce a new composition of matter having the desired characteristics which differ from those of the component constituents. Certain of these constituents, as for example trioxymethylene and naphthalene, possess dangerous characteristics when used alone and others do not possess the necessary healing qualities.
The bactericidal qualities of trioxymethelene are well recognized. However, as stated above, its use alone is frequently irritating and even dangerous. Accordingly I provide a vehicle for the trioxymethylene in which the latter is suspended in the colloidal state. The composition which I employ as a vehicle possesses remedial characteristics in addition to its function as a. carrier for the trioxymethylene or formol.
According to my invention four ingredients are employed in'the preparation of the vehicle, namely cairphor, naphthalene, benzoic acid and menthol. Of these ingredients the camphor and naphthalene react with each other to form a chemical compound having different remedial characteristics than the initial materials, while the benzoic acid and menthol likewise react to form the chemical compound, benzoate of menthyl. The reaction product of the camphor and naphthalene possesses bactericidal characteristics, and in addition serves as a vehicle for. the trioxymethylene, while the benzoate of menthyl is a reversible compound which is found to avoid the putrescent phenomena through the intermittent action of the body due to its reversibility.
The preferred method of preparing the composition will now be described. In preparing the vehicle benzoic acid, menthol, camphor and naphthalene are employed. The benzoic acid is melted at a moderate temperature'and then menthol is added in the proportion of about four parts by weight of benzoic acid to three parts by weight of menthol. These quantities are substantially molecular proportions of the benzoic acid and menthol respectively.
Next, eight parts by weight of natural camphor are added and, although the melting point of camphor is 180 C., it is better to drop down the temperature to, 150 (3., because the benzoic acid acts as a melter. As soon as the camphor is melted, purified naphthalene is added in a proportion of about five parts by weight.
Reactions take place between the benzoic acid and menthol and between the camphor and naphthalene. An excess of camphor is preferably employed-over the molecular quantity and such excess camphor acts as a solvent for the two reaction products.
To the vehicle produced as described, a quan: tity of trioxymethylene, or formol, is added, pref erably. in a proportion of five parts by weight of trioxymethylene oriormol to one hundred parts by weight of the vehicle. The trioxymethylene is suspended in thecolloidal state in the vehicle. It seems probable that a reaction takes place between some of the trioxymethylene and the excess camphor. If desired, zinc oxide may be added, in a proportion of about 210 parts by weight to 100 parts of the vehicle and 5 parts of trioxymethylene. The zinc oxide serves as a filler principally, but is a desirable constituent by reason of its known medical properties. Vaseline, castor oil, lanolin or other fatty substances may be employed in addition to the above men--' tioned ingredients in order to give the salve the proper cnisistency.
The reaction between the menthol and benzoic mo on.o.oo.c
H1O CH2 HO 6H HC- Menthol benzoic acid=HzO benzoate of menthyl (a reversible reaction).
The reaction between the camphor and haphthalene is as follows:
2C1oHs+3C1oH1sO= (CioHs) 2. (0101-1160) 3 (2 molecules of) (3 molecules /1 molecule reaction naphthalene of camphor product The reaction product of the camphor and naphthalene may be used alone as a vehicle for the trioxymethylene or formol, but the medicinal properties of such a composition are not so effective as where-a. vehicle comprising both the reaction products of menthol and benzoic acid and of camphor and naphthalene are employed in conjunction with the trioxymethylene in colloidal suspension.
Utilization of the bactericidal and antiseptic qualities of the trioxymethylene or formol constitutes an important factor in the improved composition, because when combined with the vehicle a stable composition is formed, with a considerable increase in the antiseptic properties. Moreover, the diifusing and impregnating qualities of the composition are much superior to those of the initial ingredients. Zinc oxide readily comp bines with the composition of matter, and while improving the physical characteristics of the composition as a whole, it also improves the remedial qualities of the composition.
This preparation may be readily made up in various strengths diluted with various oily or fatty mediums, such as Vaseline, castor oil, lanolin, or the like, in which it may remain indefinitely while retaining its medicinal qualities.
The medicament is intended for external use, and since it is a synergetic antiseptic, not toxic, and not destructive of tissues, it may be employed in the treatment of all, kinds of lesions caused or complicated by the presence of germs, particularly pyogenic micro-organisms.
The medicament acts as a stimulant of cellular repairing in all cases of loss of substance, of pathological as well as of surgical origin, this effect being particularly noticeable in the case of lesions which are slow to heal.
. The innocuity of the antiseptic not only when in contact with the skin, but also where used on subcutaneous tissue, muscles, bones, pleura, peritoneum and all epitheliums investing most of the natural cavities makes the substance valuable in the toxi-infectious lesions of organic structures referred to above.
The medicament may be used in the customary manner known to the surgical practice; it is directly applied in the case of burns, ulcers, fistulas and the like. In the case of canalization, gauzes, tubes or dressings are impregnated with the medicament and applied according to the requirements of the case. In deep inaccessible lesions the medicament is dissolved in liquid vaseline and conducted to the lesion through cathapplication which includes as an important ingredient thereof a reaction product of naphthalene and camphor.
2. A medical composition adapted for external application which includes as an important ingredient thereof a reaction product of menthol and benzoic acid.
3. A medical composition adapted for external application which includes as important ingredients the reaction products of (1) menthol and benzoic acid and (2) naphthalene and camphor.
4. A stable medical composition adapted for external application which includes as an important ingredient trioxymethylene colloidally suspended in a vehicle, which vehicle includes as an important ingredient a reaction product of naphthalene and camphor.
5. A stable medical composition adapted for external application which includes as an important ingredient trioxymethylene colloidally suspended in a vehicle comprising (1) a reaction. product of benzoic acid and menthol and (2) a reaction product of camphor and naphthalene.
6. A process of producing a stable medical composition which comprises mixing melted benzoic acid and menthol, then adding camphor and naphthalene, heating until a reaction takes place between the benzoic acid and menthol and between the camphor and naphthalene, and then adding trioxymethylene or formol and mixing to obtain a colloidal suspension of the trioxymethylene in a vehicle comprising the reaction products of the menthol and benzoic acid and of the camphor and naphthalenea 7. A medical composition as set forth in claim 7 1, together with a solvent for the reaction prod-' uct consisting of uncombined camphor.
8. A medical composition as set forth in claim 2, together with a solvent for the reaction product consisting of camphor. I
9. A medical composition as set forth in claim 3, together with a solvent for the reaction products consisting of uncombined camphor.
10. A process of producing a'vehicle for trioxymethylene, having medicinal properties, which comprises mixing melted benzoic acid and menthol in substantially molecular proportions, then adding camphor and naphthalene, the camphor being employed in excess of the molecular proportions, and heating until a reaction takes place between the benzoic acid and menthol and between the camphor and naphthalene, the excess camphor serving as a solvent for the reac tion products.
ANGEL ZIMIBRON, ,JR. EL. s.]
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US629993A US1982148A (en) | 1932-08-22 | 1932-08-22 | Medicament for external use and method of producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US629993A US1982148A (en) | 1932-08-22 | 1932-08-22 | Medicament for external use and method of producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US1982148A true US1982148A (en) | 1934-11-27 |
Family
ID=24525311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US629993A Expired - Lifetime US1982148A (en) | 1932-08-22 | 1932-08-22 | Medicament for external use and method of producing the same |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US1982148A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090176876A1 (en) * | 2008-01-04 | 2009-07-09 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially decolletage |
| US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
| US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7927614B2 (en) | 2006-02-03 | 2011-04-19 | Jr Chem, Llc | Anti-aging treatment using copper and zinc compositions |
| US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
| US9427397B2 (en) | 2009-01-23 | 2016-08-30 | Obagi Medical Products, Inc. | Rosacea treatments and kits for performing them |
-
1932
- 1932-08-22 US US629993A patent/US1982148A/en not_active Expired - Lifetime
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7927614B2 (en) | 2006-02-03 | 2011-04-19 | Jr Chem, Llc | Anti-aging treatment using copper and zinc compositions |
| US8148563B2 (en) | 2006-02-03 | 2012-04-03 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
| US20090176876A1 (en) * | 2008-01-04 | 2009-07-09 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially decolletage |
| US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
| US8505730B2 (en) | 2008-01-04 | 2013-08-13 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
| US9427397B2 (en) | 2009-01-23 | 2016-08-30 | Obagi Medical Products, Inc. | Rosacea treatments and kits for performing them |
| US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69229548T2 (en) | ANTIMICROBIAL COMPOSITIONS FOR MEDICAL APPLICATIONS | |
| DE2736777A1 (en) | SPRAYABLE Germicidal Foam Compositions | |
| JPH0212451B2 (en) | ||
| DE10337340A1 (en) | composition | |
| US9757328B2 (en) | Lysozyme gel formulations | |
| US1982148A (en) | Medicament for external use and method of producing the same | |
| EP0472575A1 (en) | Improvements in or relating to pharmaceutical preparations | |
| EP2555784B1 (en) | Honey-based gel composition | |
| US1676554A (en) | Topical medicine | |
| CN106511326A (en) | Repairing type disinfection liquid | |
| WO1996013284A1 (en) | Wound treatment composition | |
| US3751565A (en) | Therapeutic compositions | |
| JP6725108B2 (en) | Disinfecting composition containing unithiol and dimethyl sulfoxide, use of the composition and method for treating wound using the same | |
| CN115813822B (en) | High-efficiency acne-removing composition and preparation method thereof | |
| CN101380316B (en) | Multifunctional external antibiotic preparation and production method thereof | |
| US2209454A (en) | Germicide | |
| US2788308A (en) | Topical non-aqueous acetic compositions | |
| CN1994477A (en) | Method for preparing medical dressing | |
| US2385262A (en) | Therapeutic-anesthetic preparations | |
| US1924169A (en) | Antiseptic preparation | |
| US20210290666A1 (en) | ANTIMICROBIAL and ANTI-INFLAMMATORY COMPOSITION | |
| US3803179A (en) | Phenyl-propyl-d-alpha-tocopherol-succinate and preparation | |
| CN105709272A (en) | Novel biological antibacterial dressing for wound surface treatment | |
| US20110046532A1 (en) | composition including a silicone-based polymer and a method of treating skin disorders using the composition | |
| JPS6172707A (en) | Cosmetics for acne |